GHSI Stock - Guardion Health Sciences, Inc.
Unlock GoAI Insights for GHSI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $12.25M | $11.05M | $7.23M | $1.89M | $902,937 |
| Gross Profit | $5.39M | $4.52M | $3.11M | $-56,791 | $561,622 |
| Gross Margin | 44.0% | 40.9% | 43.0% | -3.0% | 62.2% |
| Operating Income | $-4,336,317 | $432,678 | $-10,483,378 | $-8,551,731 | $-8,933,417 |
| Net Income | $158,033 | $-30,277,134 | $-24,745,009 | $-8,578,928 | $-11,136,673 |
| Net Margin | 1.3% | -274.0% | -342.1% | -453.9% | -1233.4% |
| EPS | $0.12 | $-27.01 | $-52.23 | $-180.53 | $-91.61 |
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Visit WebsiteEarnings History & Surprises
GHSIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 11, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q4 2024 | Nov 11, 2024 | — | — | — | — |
Q3 2024 | Aug 13, 2024 | $-0.66 | $-1.64 | -148.5% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-0.88 | $-3.71 | -321.6% | ✗ MISS |
Q1 2024 | Mar 28, 2024 | $-0.73 | $0.33 | +145.2% | ✓ BEAT |
Q4 2023 | Nov 13, 2023 | $-0.87 | $0.29 | +133.3% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.93 | $-0.93 | 0.0% | = MET |
Q2 2023 | May 15, 2023 | $-1.13 | $0.42 | +137.2% | ✓ BEAT |
Q2 2023 | Apr 17, 2023 | $-1.50 | $-19.13 | -1175.5% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-1.00 | $-1.50 | -50.0% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-2.25 | $-1.50 | +33.3% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-4.00 | $-3.50 | +12.5% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $-39.50 | $-5.00 | +87.3% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | — | $-6.00 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-5.00 | — | — |
Q2 2021 | May 17, 2021 | — | $-6.50 | — | — |
Q1 2021 | Mar 26, 2021 | — | $-11.50 | — | — |
Q4 2020 | Nov 12, 2020 | — | $-6.00 | — | — |
Q3 2020 | Aug 12, 2020 | — | $-3.00 | — | — |
Latest News
Frequently Asked Questions about GHSI
What is GHSI's current stock price?
What is the analyst price target for GHSI?
What sector is Guardion Health Sciences, Inc. in?
What is GHSI's market cap?
Does GHSI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GHSI for comparison